Form 4: Royalty Pharma Director Bonnie L. Bassler Acquires Shares in Lieu of Retainer

Director Bonnie L. Bassler acquired 1,503 Class A Ordinary Shares of Royalty Pharma plc on December 31, 2024, in lieu of a $37,500 quarterly retainer payment.

Summary

• On December 31, 2024, Bonnie L. Bassler, a director of Royalty Pharma plc, acquired 1,503 Class A Ordinary Shares.
• The shares were issued under the Issuer's 2020 Independent Director Equity Incentive Plan.
• The acquisition was in lieu of a quarterly retainer payment of $37,500, with the shares acquired at a price of $24.9416 each.
• Following the transaction, Bassler directly owns 61,299 Class A Ordinary Shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director taking shares in lieu of cash compensation signals confidence and helps the company conserve cash.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• Using equity in lieu of cash preserves cash for the company.

Industry Context

Director compensation using company stock is a common practice to align the interests of directors with those of shareholders. This approach can also help the company conserve cash.

Stakeholder Impact

• Shareholders may view the director's acceptance of shares positively, as it aligns their interests with the company's performance.
• The company benefits from preserving cash by issuing shares instead of making a cash payment.

Key Dates